The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model

Experimental Neurology

Volumn 257, Issue , 2014, Pages 76-87

  Gonçalves, Nádia Pereira ^a,b   Teixeira Coelho, Maria ^a   Saraiva, Maria João ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cytokines; Inflammation; Nerve injury; Neuroinflammation; Regeneration; Schwann cells; Transthyretin

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1BETA; MUTANT PROTEIN; PREALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; IMMUNOREGULATION; INNATE IMMUNITY; MALE; MOLECULAR PATHOLOGY; MOUSE; NERVE DEGENERATION; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHWANN CELL; SCIATIC NERVE INJURY; TISSUE SPECIFICITY; WILD TYPE;

CYTOKINES; INFLAMMATION; NERVE INJURY; NEUROINFLAMMATION; REGENERATION; SCHWANN CELLS; TRANSTHYRETIN;

AMYLOID NEUROPATHIES, FAMILIAL; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FUNCTIONAL LATERALITY; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LOCOMOTION; MALE; METHIONINE; MICE; MICE, TRANSGENIC; MUTATION; PAIN MEASUREMENT; PREALBUMIN; SCHWANN CELLS; SCIATIC NEUROPATHY; TIME FACTORS; VALINE;

EID: 84900864199     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.04.030     Document Type: Article

References (58)

1. Alvarez R., Borland T., Chen Q., Milstein S., Nguyen T., Hinkle G., Kuchimanchi S., Costigan J., Ristoiu V., Wang G., Cole G., Dorkin R., Akinc A., Nechev L., Kosovrasti V., Tchangov L., Tracy M., Jeffs L., MacLachlan I., Lutwyche P., Martins D., Costelha S., Saraiva M.J., Sah D.W.Y. ALN-TTR, an RNAi therapeutic for the treatment of transthyretin-mediated Amyloidosis. Amyloid 2010, 17(s1):51-52.
2. Arthur-Farraj P.J., Latouche M., Wilton D.K., Quintes S., Chabrol E., Banerjee A., Woodhoo A., Jenkins B., Rahman M., Turmaine M., Wicher G.K., Mitter R., Greensmith L., Behrens A., Raivich G., Mirsky R., Jessen K.R. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 2012, 75:633-647.
3. Austin P.J., Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol. 2010, 229:26-50.
4. Bain J.R., Mackinnon S.E., Hunter D.A. Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast. Reconstr. Surg. 1989, 83:129-136.
5. Barrette B., Hébert M.A., Filali M., Lafortune K., Vallières N., Gowing G., Julien J.P., Lacroix S. Requirement of myeloid cells for axon regeneration. J. Neurosci. 2008, 28:9363-9376.
6. Benson M.D., Kincaid J.C. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007, 36:411-423.
7. Brumovsky P.R., Bergman E., Liu H.X., Hökfelt T., Villar M.J. Effect of a graded single constriction of the rat sciatic nerve on pain behavior and expression of immunoreactive NPY and NPY Y1 receptor in DRG neurons and spinal cord. Brain Res. 2004, 1006:87-99.
8. Buxbaum J.N., Tagoe C., Gallo G., Walker J.R., Kurian S., Salomon D.R. Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?. FASEB J. 2012, 26:2283-2293.
9. Chau C.H., Shum D.K., Chan Y.S., So K.F. Heparan sulphates upregulate regeneration of transected sciatic nerves of adult guinea-pigs. Eur. J. Neurosci. 1999, 11:1914-1926.
10. Coimbra A., Andrade C. Familial amyloid polyneuropathy: an electron microscope study of peripheral nerve in five cases. II. Nerve fibril changes. Brain 1971, 94:207-212.
11. Colon W., Kelly J.W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 1992, 31:8654-8660.
12. Cornwell G.G., Murdoch W.L., Kyle R.A., Westermark P., Pitkänen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am. J. Med. 1983, 75:618-623.
13. de Medinaceli L., Freed W.J., Wyatt R.J. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp. Neurol. 1982, 77:634-643.
14. Fleming C.E., Saraiva M.J., Sousa M.M. Transthyretin enhances nerve regeneration. J. Neurochem. 2007, 103:831-839.
15. Gaudet A.D., Popovich P.G., Ramer M.S. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J. Neuroinflammation 2011, 8:110.
16. Girard C., Liu S., Cadepond F., Adams D., Lacroix C., Verleye M., Gillardin J.M., Baulieu E.E., Schumacher M., Schweizer-Groyer G. Etifoxine improves peripheral nerve regeneration and functional recovery. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:20505-20510.
17. Goethals S., Ydens E., Timmerman V., Janssens S. Toll-like receptor expression in the peripheral nerve. Glia 2010, 58:1701-1709.
18. Gonçalves N.P., Oliveira H., Pêgo A.P., Saraiva M.J. A novel nanoparticle delivery system for in vivo targeting of the sciatic nerve: impact on regeneration. Nanomedicine (Lond.) 2012, 7:1167-1180.
19. Gonçalves N.P., Pêgo A.P., Saraiva M.J. Heparin/Chitosan nanoparticle delivery system for in vivo evaluation of glycosaminoglycans influence on transthyretin deposition. XIIIth International Symposium on Amyloidosis 2013, 118-121. GUARD, Groningen, Netherlands. B.P.C. Hazenberg, J. Bijzet (Eds.).
20. Haraguchi K., Kawamoto A., Isami K., Maeda S., Kusano A., Asakura K., Shirakawa H., Mori Y., Nakagawa T., Kaneko S. TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. J. Neurosci. 2012, 32:3931-3941.
21. Hare G.M.T., Evans P.J., Mackinnon S.E., Best T.J., Bain J.R., Szalai J.P., Hunter D.A. Walking track analysis: a long-term assessment of peripheral nerve recovery. Plast. Reconstr. Surg. 1992, 89:251-258.
22. Heskamp A., Leibinger M., Andreadaki A., Gobrecht P., Diekmann H., Fischer D. CXCL12/SDF-1 facilitates optic nerve regeneration. Neurobiol. Dis. 2013, 55:76-86.
23. Kanai M., Raz A., Goodman D.S. Retinol-binding protein: the transport protein for vitamin A in human plasma. J. Clin. Invest. 1968, 47:2025-2044.
24. Kohno K., Palha J.A., Miyakawa K., Saraiva M.J., Ito S., Mabuchi T., Blaner W.S., Iijima H., Tsukahara S., Episkopou V., Gottesman M.E., Shimada K., Takahashi K., Yamamura K., Maeda S. Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am. J. Pathol. 1997, 150:1497-1508.
25. Koike H., Misu K., Sugiura M., Iijima M., Mori K., Yamamoto M., Hattori N., Mukai E., Ando Y., Ikeda S., Sobue G. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 2004, 63:129-138.
26. Lai Z., Colón W., Kelly J.W. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 1996, 35:6470-6482.
27. Misu Ki, Hattori N., Nagamatsu M., Ikeda Si, Ando Y., Nakazato M., Takei Yi, Hanyu N., Usui Y., Tanaka F., Harada T., Inukai A., Hashizume Y., Sobue G. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999, 122:1951-1962.
28. Mueller M., Leonhard C., Wacker K., Ringelstein E.B., Okabe M., Hickey W.F., Kiefer R. Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab. Invest. 2003, 83:175-185.
29. Murakami T., Ohsawa Y., Zhenghua L., Yamamura K., Sunada Y. The transthyretin gene is expressed in Schwann cells of peripheral nerves. Brain Res. 2010, 1348:222-225.
30. Nadeau S., Filali M., Zhang J., Kerr B.J., Rivest S., Soulet D., Iwakura Y., de Rivero Vaccari J.P., Keane R.W., Lacroix S. Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1β and TNF: implications for neuropathic pain. J. Neurosci. 2011, 31:12533-12542.
31. Nagata Y., Tashiro F., Yi S., Murakami T., Maeda S., Takahashi K., Shimada K., Okamura H., Yamamura K. A 6-kb upstream region of the human transthyretin gene can direct developmental, tissue-specific, and quantitatively normal expression in transgenic mouse. J. Biochem. 1995, 117:169-175.
32. Niemi J.P., Defrancesco-Lisowitz A., Roldán-Hernández L., Lindborg J.A., Mandell D., Zigmond R.E. A critical role for macrophages near axotomized neuronal cell bodies in stimulating nerve regeneration. J. Neurosci. 2013, 33:16236-16248.
33. Noborn F., O'Callaghan P., Hermansson E., Zhang X., Ancsin J.B., Damas A.M., Dacklin I., Presto J., Johansson J., Saraiva M.J., Lundgren E., Kisilevsky R., Westermark P., Li J.P. Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5584-5589.
34. Nyhlin N., Ando Y., Nagai R., Suhr O., El Sahly M., Terazaki H., Yamashita T., Ando M., Horiuchi S. Advanced glycation end product in familial amyloidotic polyneuropathy (FAP). J. Intern. Med. 2000, 247:485-492.
35. Oliveira S.M., Ribeiro C.A., Cardoso I., Saraiva M.J. Gender-dependent transthyretin modulation of brain amyloid-β levels: evidence from a mouse model of Alzheimer's disease. J. Alzheimers Dis. 2011, 27:429-439.
36. Pearson A.G., Gray C.W., Pearson J.F., Greenwood J.M., During M.J., Dragunow M. ATF3 enhances c-Jun-mediated neurite sprouting. Brain Res. Mol. Brain Res. 2003, 120:38-45.
37. Puchtler H., Sweat F. Congo Red as a stain for fluorescence microscopy of amyloid. J. Histochem. Cytochem. 1965, 13:693-694.
38. Quintas A., Vaz D.C., Cardoso I., Saraiva M.J., Brito R.M. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J. Biol. Chem. 2001, 276:27207-27213.
39. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
40. Saraiva M.J., Sousa M.M. Neurodegeneration in familial amyloidotic polyneuropathy: from pathology to molecular signaling. Prog. Neurobiol. 2003, 71:385-400.
41. Saraiva M.J., Birken S., Costa P.P., Goodman D.S. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J. Clin. Invest. 1984, 74:104-119.
42. Sasaki H., Tone S., Nakazato M., Yoshioka K., Matsuo H., Kato Y., Sakaki Y. Generation of transgenic mice producing a human transthyretin variant: a possible mouse model for familial amyloidotic polyneuropathy. Biochem. Biophys. Res. Commun. 1986, 139:794-799.
43. Scholz J., Woolf C. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 2007, 10:1361-1368.
44. Semple S.C., et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 2010, 28:172-176.
45. Sensenbrenner M., Lucas M., Deloulme J.C. Expression of two neuronal markers, growth-associated protein 43 and neuron-specific enolase, in rat glial cells. J. Mol. Med. (Berl.) 1997, 75:653-663.
46. Shamash S., Reichert F., Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 2002, 22:3052-3060.
47. Sheu M.L., Cheng F.C., Su H.L., Chen Y.J., Chen C.J., Chiang C.M., Chiu W.T., Sheehan J., Pan H.C. Recruitment by SDF-1α of CD34-positive cells involved in sciatic nerve regeneration. J. Neurosurg. 2012, 116:432-444.
48. Smith D.F., Galkina E., Ley K., Huo Y. GRO family chemokines are specialized for monocyte arrest from flow. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:1976-1984.
49. Soprano D.R., Herbert J., Soprano K.J., Schon E.A., Goodman D.S. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J. Biol. Chem. 1985, 260:11793-11798.
50. Sousa M.M., Du Yan S., Fernandes R., Guimaraes A., Stern D., Saraiva M.J. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J. Neurosci. 2001, 21:7576-7586.
51. Sousa M.M., Cardoso I., Fernandes R., Guimarães A., Saraiva M.J. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am. J. Pathol. 2001, 159:1993-2000.
52. Sousa M.M., do Amaral J.B., Guimarães A., Saraiva M.J. Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy. FASEB J. 2005, 19:124-126.
53. Tsujino H., Kondo E., Fukuoka T., Dai Y., Tokunaga A., Miki K., Yonenobu K., Ochi T., Noguchi K. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. Mol. Cell. Neurosci. 2000, 15:170-182.
54. Van Vactor D., Wall D.P., Johnson K.G. Heparan sulfate proteoglycans and the emergence of neuronal connectivity. Curr. Opin. Neurobiol. 2006, 16:40-51.
55. Westermark P. Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 2005, 272:5942-5949.
56. Woeber K.A., Ingbar S.H. The contribution of thyroxinebinding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J. Clin. Invest. 1986, 47:1710-1721.
57. Yamamura K., Wakasugi S., Maeda S., Inomoto T., Iwanaga T., Uehira M., Araki K., Miyazaki J., Shimada K. Tissue-specific and developmental expression of human transthyretin gene in transgenic mice. Dev. Genet. 1987, 8:195-205.
58. Ydens E., Lornet G., Smits V., Goethals S., Timmerman V., Janssens S. The neuroinflammatory role of Schwann cells in disease. Neurobiol. Dis. 2013, 55:95-103.